The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Disitamab vedotin combined with fruquintinib in patients with HER2-expressing or HER2 mutation/amplified metastatic colorectal cancer refractory to at least two standard regimens: A prospective, exploratory, single-arm study.
 
Hui Xu
No Relationships to Disclose
 
Jin Peng
No Relationships to Disclose
 
Han Wu
No Relationships to Disclose
 
Lei Yang
No Relationships to Disclose
 
Wenbo Wang
No Relationships to Disclose
 
You Wang
No Relationships to Disclose
 
Xin Long
No Relationships to Disclose
 
Linli He
No Relationships to Disclose
 
Fuxiang Zhou
No Relationships to Disclose